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Many degenerative diseases are associated with increased 
oxidative stress. Creatine has the potential to act as an indirect 
and direct antioxidant; however, limited data exist to evaluate the 
antioxidant capabilities of creatine supplementation within in 
vivo human systems. This study aimed to investigate the effects 
of oral creatine supplementation on markers of oxidative stress 
and antioxidant defenses following exhaustive cycling exercise. 
Following preliminary testing and two additional familiarization 
sessions, 18 active males repeated two exhaustive incremental 
cycling trials (T1 and T2) separated by exactly 7 days. The 
subjects were assigned, in a double-blind manner, to receive either 
20 g of creatine (Cr) or a placebo (P) for the 5 days preceding T2. 
Breath-by-breath respiratory data and heart rate were continually 
recorded throughout the exercise protocol and blood samples were 
obtained at rest (preexercise), at the end of exercise (postexercise), 
and the day following exercise (post24 h). Serum hypdroper-
oxide concentrations were elevated at postexercise by 17 ± 5% 
above preexercise values (p = 0.030). However, supplementation 
did not influence lipid peroxidation (serum hypdroperoxide 
concentrations), resistance of low density lipoprotein to oxida-
tive stress (t1/2max LDL oxidation) and plasma concentrations 
of non-enzymatic antioxidants (retinol, α-carotene, β-carotene, 
α-tocopherol, γ-tocopherol, lycopene and vitamin C). Heart rate 
and oxygen uptake responses to exercise were not affected by 
supplementation. These findings suggest that short-term 
creatine supplementation does not enhance non-enzymatic anti-
oxidant defence or protect against lipid peroxidation induced by 
exhaustive cycling in healthy males.
Introduction
Creatine monohydrate has become a popular supplement, which 
is reputed to elevate intramuscular high-energy phosphates and 
thereby act as a temporal energy buffer to allow more work to be 
completed during high-intensity exercise.1 Creatine is a nitrogenous 
organic acid that is endogenously synthesized, predominantly in the 
liver, from glycine, arganine and methionine. Oral consumption of 
creatine monohydrate has been demonstrated to increase plasma 
creatine concentrations2 and enhance total creatine concentra-
tions,3 which is mostly stored as creatine phosphate (CrP) within 
skeletal muscles. Consequently, creatine monohydrate supple-
mentation has the potential to improve performance during 
high-intensity exercise.
In addition to its ergogenic properties, creatine might augment 
cellular energy supply and attenuate the loss of cellular Ca2+ 
homeostasis that has been associated with a range of disease popu-
lations.4 As the accumulation of intracellular Ca2+ has been widely 
implicated in the formation of reactive oxygen species (ROS) and 
oxidative damage,5 creatine supplementation has the potential to 
improve Ca2+ homeostasis, reduce ROS production and lessen 
oxidative damage. Lawler et al.6 were the first to report direct 
antioxidant properties of creatine. In a series of highly controlled 
in-vitro studies, these authors demonstrated that creatine was 
effective in scavenging a range of radicals, including superoxide 
anion. More recently, exogenous creatine has been demonstrated 
to scavenge ROS (including hydroxyl radical) as well as reactive 
nitrogen species in cultured human cells.7
There is a growing body of evidence to suggest that creatine 
supplementation might be beneficial in the prevention and/or treat-
ment of a number of neuromuscular and cardiovascular diseases, 
for which oxidative stress has been consistently associated. For 
example, creatine has been demonstrated to improve a variety of 
outcome measures in animal models of neurodegenerative diseases, 
such as Huntington’s disease,8 Parkinson’s disease,9 amyotrophic 
lateral sclerosis10,11 and other metabolic disorders.12 Also, pretreat-
ment with creatine has been shown to protect against ischemic 
injury in rodent models of stroke13,14 and creatine supplementation 
is an effective adjunct therapy in the protection of cardiac function 
and antioxidant defences in ovariectomized hamsters.15
Oxidative stress within the mitochondrial has been associated 
with aging, where oxidized nucleotides have been demonstrated to 
accumulate in the brain and muscle with age.16 Additionally, several 
studies have linked aging with reductions in the mRNA of genes 
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associated with mitochondrial structure and function in skeletal 
muscle and the accumulation of mitochondrial DNA mutations.17 
Consequently, mitochondrial dysfunction has been implicated in a 
downward spiral, whereby elevated ROS production causes further 
mitochondrial damage, mitochondrial dysfunction and increased 
oxidative stress.
Although a small number of reports, mainly anecdotal in nature, 
suggest that creatine supplementation has the potential to reduce 
oxidative stress in diseased populations,18,19 the individualized 
nature of these degenerative diseases makes long-term random-
ized controlled clinical trials difficult to perform. Consequently, 
the efficacy of creatine in reducing oxidative stress in humans is 
unclear. It has been estimated that approximately 2–5% of the 
oxygen flux through the mitochondria is not completely reduced 
to water and generates ROS,20 such as superoxide anions and 
hydroxyl radicals. Under normal resting conditions, elaborate 
antioxidant defences are able to prevent oxidative damage to 
biological molecules including lipids, amino acids and nucle-
otides.21 Exercise provoking large increases in whole-body oxygen 
uptake has the potential to generate ROS (particularly superoxide 
anions) through the reperfusion of hypoxic tissues in addition to 
ROS produced through the elevated mitochondrial oxygen flux. 
Therefore, strenuous concentric muscle activity could increase 
ROS production, overwhelm normal antioxidant defences, and 
induce oxidative stress; indeed, exhaustive cycling has been demon-
strated to elevate measurements of ROS and lipid peroxidation in 
apparently healthy humans.22
Creatine has potential antioxidant properties (direct and indi-
rect) and has been shown to reduce free radical production and 
oxidative stress in various animal models of disease; however, 
limited in-vivo data exists to evaluate the effects of oral creatine 
monohydrate supplementation on oxidative stress in humans. 
Therefore, the purpose of the current study was to investigate the 
proposed antioxidant effects of short-term creatine monohydrate 
supplementation on antioxidant defences and oxidative stress 
following exhaustive cycling exercise.
Results
The environmental conditions were similar during all trials, 
ambient temperature being 21.8 ± 0.1 and 21.9 ± 0.2°C, baro-
metric pressure 766 ± 1 and 766 ± 2 mmHg, and humidity 
45.2 ± 1.8 and 44.3 ± 1.9%, for T1 and T2 respectively. The 
calculated daily diet comprised of 8.9 ± 0.3 MJ·d-1, of which 
45 ± 2, 32 ± 2, 17 ± 1 and 6 ± 3% of energy intake was 
obtained from carbohydrates, fat, protein and alcohol, respectively. 
No differences were identified between groups or trials for calcu-
lated antioxidant vitamin intakes (Vitamin A: 528 ± 2.6 μg·d-1; 
Vitamin C: 47 ± 6 mg·d-1; Vitamin E: 6.1 ± 0.5 mg·d-1).
Peak exercising heart rate and whole-body oxygen uptake were 
similar during all trials (Table 1), being 194 ± 1 beats min-1 and 
3.97 ± 0.07 L·min-1, respectively. Net whole-body oxygen uptake 
during exercise (55.5 ± 2.1 L) was similar between supplementation 
groups and did not change following supplementation (Table 1).
Supplementation did not influence changes in plasma volume 
(trial x timing x group effect, p = 0.359) and these values were 
similar between trials (trial effect, p = 0.146), being -9.7 ± 0.8% 
from preexercise values at postexercise and returning to preexercise 
values at post24 h (1.6 ± 1.3%).
Blood lactate concentrations were similarly elevated from 
preexercise (1.12 ± 0.06 mmol·L-1) at postexhaustion (8.31 ± 
0.21 mmol·L-1) and postexercise (4.98 ± 0.20 mmol·L-1) during 
all trials (p < 0.001) (Table 2). Blood glucose concentrations 
were not significantly different for preexercise, postexhaustion, 
postexercise and post24 h, being 4.17 ± 0.09, 4.35 ± 0.07 and 4.32 
± 0.07 mmol·L-1, respectively, for all trials (Table 2).
Exercise did not change t1/2max LDL oxidation (time of sample 
effect, p = 0.502) and supplementation did not influence the 
pattern of these values (trial x timing of sample x group effect, 
p = 0.331), with preexercise, postexercise and post24 h 
values being 97.5 ± 3.9, 96.6 ± 3.8, 96.1 ± 4.3 min, respectively 
(Table 2).
Serum hypdroperoxide concentrations were elevated at postex-
ercise by 17 ± 5% above preexercise values (time of sample effect, 
p = 0.030) in all trials (Fig. 1). The three-way interaction effect 
was not significant (trial x timing of sample x group effect, p 
= 0.205) and no difference existed between trials (trial effect, 
p = 0.959).
Supplementation did not influence the pattern of response 
in any of the measured antioxidant vitamins (trial x timing of 
sample x group effect, p ≥ 0.176). Exercise elevated plasma 
concentrations of retinol by 7.2 ± 3.0% (time of sample effect, 
p = 0.015). Plasma concentrations of α-carotene, β-carotene, 
α-tocopherol, γ-tocopherol, lycopene and vitamin C were similar 
throughout the duration of each trial and were not significantly 
different between trials (time of sample effect, p ≥ 0.078) 
(Table 3).
Discussion
The main findings of this study were that creatine supplementa-
tion (20 g·d-1 of creatine administered for 5 d) was not effective in 
attenuating oxidative stress, did not influence the  concentrations 
of non-enzymatic antioxidant vitamins, and did not alter the 
susceptibility of LDL particles to oxidative stress in previously 
familiarized healthy individuals.
Creatine supplementation and oxidative stress
Table 1  Heart rate and oxygen uptake responses to 
exhaustive exercise before (Trial 1) and after 
(Trial 2) supplementation with creatine and 
placebo
  Trial 1 Trial 2 Effect: P 
    interaction, 
    trial
Peak Heart Rate Cr 195 ± 3 194 ± 3 0.719 
(beats·min-1) P 193 ± 2 192 ± 1 0.523
Peak Oxygen Uptake  Cr 3.92 ± 0.15 3.83 ± 0.13 0.739 
(L·min-1) P 4.01 ± 0.14 4.02 ± 0.18 0.399
Net Oxygen Uptake Cr 52.22 ± 3.28 51.46 ± 3.18 0.971 
(L) P 58.86 ± 4.81 59.66 ± 4.77 0.145
Values are last minute values; presented as mean ± SEM (N = 9). Definitions: Cr, Creatine group; 
P, Placebo group. Effects present p-values for supplementation group x trial interaction effect and trial 
effect.
Creatine supplementation and oxidative stress
 electron spin resonance (ESR) signal in the plasma of healthy 
young subjects.22 These authors suggested that the enhanced 
postexercise ESR signal reflected an increase in the concentration 
of alkoxyl radicals formed as a consequence of primary ROS (such 
as superoxide anion and hydroxyl radicals) attack on membrane 
phospholipids.
The amount of external work undertaken during the indi-
vidualised exhaustive protocol was matched during T1 and 
T2; furthermore, heart rate, oxygen uptake and blood lactate 
concentrations reached similar peak values at the end of exercise 
during all trials suggesting that the protocol challenged all subjects 
to an equal extent. Net whole-body oxygen uptake was similar 
between groups and trials (Table 2). Assuming that the rate of 
mitochondrial ROS production remained approximately constant 
The cycling protocol increased lipid peroxidation above 
preexercise values, as measured by increased postexercise serum 
hypdroperoxide concentrations. The relative change in lipid 
peroxidation (17 ± 5%) was less than we previously reported after 
intermittent running, where increases of 24 ± 5% were measured.23 
Exhaustive cycling does not involve significant amounts of eccen-
tric muscle activity and structural muscle damage; therefore, unlike 
intermittent running, cycling does not lead to inflammation-
mediated free radical production that follows structural muscle 
damage.24 Consequently, during the current study, it is likely 
that increased mitochondrial oxygen flux led to elevated ROS 
production that overwhelmed the antioxidant defences and caused 
oxidative stress. In support of this premise, incremental cycling 
has previously been demonstrated to increase the intensity of the 
Table 2  Conjugated diene lag times and blood concentrations of lactate and glucose before (trial 1) and after 
(trial 2) supplementation with creatine (Cr) and placebo (P)
  Trial 1 Trial 1 Trial 1 Trial 1 Trial 2 Trial 2 Trial 2 Trial 2 Effect: P 
  Preexercise Postexhaustion Postexercise Post24 h Preexercise Postexhaustion Postexercise Post24 h  interaction, 
          timing
Lactate Cr 1.02 ± 0.08 8.21 ± 0.52 5.00 ± 0.38 0.89 ± 0.08 1.04 ± 0.10 8.51 ± 0.49 5.23 ± 0.48 1.09 ± 0.20 0.585 
(mmol·L-1) P 1.08 ± 0.14 8.25 ± 0.42 4.90 ± 0.41 1.29 ± 0.28 1.33 ± 0.16 8.26 ± 0.34 4.80 ± 0.35 1.34 ± 0.20 <0.001
Glucose Cr 4.14 ± 0.17 4.18 ± 0.14 4.44 ± 0.25 4.09 ± 0.08 3.85 ± 0.19 4.25 ± 0.12 4.44 ± 0.26 4.29 ± 0.10 0.132 
(mmol·L-1) P 4.20 ± 0.05 4.58 ± 0.11 4.74 ± 0.18 4.27 ± 0.11 4.48 ± 0.21 4.40 ± 0.16 4.48 ± 0.15 4.63 ± 0.21 0.059
t1/2max LDL Cr 89.0 ± 7.1 - 87.3 ± 6.3 88.1 ± 6.3 93.0 ± 8.4 - 91.1 ± 7.7 88.0 ± 6.1 0.502 
(min) P 102.5 ± 8.7 - 105.0 ± 7.9 100.9 ± 7.5 104.4 ± 7.3 - 103.1 ± 7.6 107.4 ± 12.4 0.393
Values are presented as mean ± SEM (N = 9). Definitions: Cr, Creatine group; P, placebo group. Effects present p-values for supplementation group x trial x timing of sample interaction effect and timing 
effect.
Figure 1. Exercise-induced lipid peroxidation as measured by serum hydroperoxide concentrations. Exhaustive cycling caused increases in lipid 
peroxidation (time of sample effect, p = 0.030), with serum hydroperoxide concentrations being elevated after exercise (ost-exercise) when compared 
with values before (Pre-exercise) and 24 hours after exercise (Post-24 h). The pattern of response was similar following supplementation with creatine 
(Cr) and placebo (P) (trial x timing of sample x group effect, p = 0.205). Values represent mean ± SEM (N = 9).
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α-carotene, β-carotene, α-tocopherol, γ-tocopherol, and lycopene, 
and vitamin C). In addition, the two main exercise trials were 
completed within 7 d; therefore, it is likely that the enzymatic 
antioxidant defences remained similar for each individual during 
both main exercise trials. As the enzymatic and non-enzymatic 
vitamin antioxidant defence were comparable between exercise 
trials, this repeated measure design was suitable to assess the influ-
ence of short-term oral creatine supplementation as an in-vivo 
antioxidant.
Supplementation did not influence the pattern of response in 
serum hydroperoxide concentrations (trial x timing of sample x 
group effect, p = 0.205). Although there was a tendency for mean 
serum hydroperoxide concentrations to be reduced following 
supplementation with creatine (Fig. 1), creatine supplementa-
tion did not significantly influence lipid peroxidation following 
exhaustive cycling. Therefore, the current finding does not 
confirm previous in-vitro data showing that creatine acts a direct 
antioxidant.6,7 Lawler et al.6 were the first to report that creatine 
effectively quenches superoxide anions and other aqueous radical 
species in highly controlled cell-free environments. Later, intrac-
ellular creatine was also shown to act as a direct antioxidant by 
scavenging ROS (particularly hydroxyl radicals) in cultured cells.7 
Mitochondrial ROS production (including superoxide anions and 
hydroxyl radicals) is likely to be the primary source of free radicals 
during cycling; consequently, it is unclear why the current creatine 
supplementation regime, which has been previously demonstrated 
to increase plasma and intramuscular creatine, was ineffective in 
attenuating lipid peroxidation in the current study.
Differences between in-vivo and in-vitro systems might partially 
explain the lack of statistical evidence to support an antioxidant 
effect in the current study. Although the current supplementation 
regime has been shown to “load” muscle cells to threshold levels,3 
considerable heterogeneity exists in intramuscular creatine uptake 
following oral supplementation. It is, therefore, possible that the 
for all individuals, the exercise protocol was effective in producing 
similar amounts of ROS during T1 and T2. Consequently, this 
repeated measures design was successful in challenging the anti-
oxidant defences of all subjects to a comparable extent during the 
main exercise trials.
The finding that creatine supplementation did not influence 
oxygen uptake during exhaustive exercise is in agreement with 
previous literature.25,26 Further evidence to suggest that cardio-
pulmonary function during exhaustive exercise was unaffected by 
creatine supplementation was provided by the similarity in heart 
rate and net oxygen uptake responses before and after supple-
mentation. In support of this conclusion, most previous studies 
that evaluate similar outcomes have failed to identify any effect 
of creatine supplementation on aerobic capacity in healthy27-31 
and diseased populations.32-34 Nevertheless, some studies have 
demonstrated that creatine supplementation can influence other 
parameters that have the potential to contribute to improved 
endurance performance. For example, creatine-induced hyper-
hydration has been shown to attenuate heart rate responses to 
prolonged exercise in the heat26 and creatine supplementation 
has been demonstrated to increase lactate threshold,27 improve 
submaximal effeciency,31 and enhance peak work capacity at 
fatigue during discontinuous exercise in elderly participants.35
It has been repeatedly demonstrated that the current creatine 
monohydrate supplementation regime is effective in increasing 
circulatory creatine concentrations2,3 and pharmacokinetic  analysis 
of plasma creatine concentrations following a 5-g oral bolus of 
creatine monohydrate showed that plasma creatine decayed with a 
half-life of approximately 2 h.36 Therefore, it is probable that the 
current supplementation protocol elevated plasma and intramus-
cular creatine concentrations.
Calculated intakes of the main dietary antioxidant vitamins 
were similar during all trials and supplementation had no effect 
on plasma concentrations of the antioxidant vitamins (retinol, 
Table 3  Plasma antioxidant vitamin concentrations before (trial 1) and after (trial 2) supplementation with  
creatine (Cr) and placebo (P)
  Trial 1 Trial 1 Trial 1 Trial 2 Trial 2 Trial 2 Effect P 
  Preexercise Postexercise Post24 h Preexercise Postexercise Post24 h interaction, timing
retinol Cr 2.1 ± 0.2 2.2 ± 0.2 2.3 ± 0.2 2.1 ± 0.2 2.3 ± 0.2 2.3 ± 0.2 0.482 
(μmol·L-1) P 2.3 ± 0.3 2.3 ± 0.3 2.4 ± 0.2 2.2 ± 0.3 2.5 ± 0.3 2.2 ± 0.2 0.015
α-carotene Cr 0.20 ± 0.05 0.22 ± 0.04 0.21 ± 0.04 0.18 ± 0.04 0.16 ± 0.04 0.17 ± 0.03 0.401 
(μmol·L-1) P 0.15 ± 0.02 0.17 ± 0.01 0.16 ± 0.02 0.15 ± 0.02 0.16 ± 0.02 0.15 ± 0.02 0.870
β-carotene Cr 0.61 ± 0.15 0.70 ± 0.13 0.70 ± 0.18 0.55 ± 0.12 0.49 ± 0.12 0.47 ± 0.10 0.176 
(μmol·L-1) P 0.42 ± 0.07 0.46 ± 0.07 0.47 ± 0.12 0.43 ± 0.07 0.53 ± 0.14 0.49 ± 0.11 0.563
α-tocopherol Cr 28.3 ± 1.8 29.1 ± 2.2 29.9 ± 2.5 28.7 ± 1.6 28.2 ± 1.8 28.2 ± 1.6 0.876 
(μmol·L-1) P 29.5 ± 2.7 31.0 ± 2.6 31.2 ± 2.6 29.5 ± 2.6 31.0 ± 2.6 31.2 ± 2.6 0.078
γ-tocopherol Cr 1.4 ± 0.1 1.3 ± 0.1 1.4 ± 0.2 1.2 ± 0.1 1.1 ± 0.1 1.2 ± 0.1 0.419 
(μmol·L-1) P 1.5 ± 0.2 1.5 ± 0.1 1.5 ± 0.1 1.5 ± 0.2 1.7 ± 0.2 1.7 ± 0.2 0.481
lycopene Cr 1.4 ± 0.3 2.0 ± 0.4 1.9 ± 0.5 1.5 ± 0.5 1.3 ± 0.3 1.2 ± 0.3 0.514 
(μmol·L-1) P 1.3 ± 0.5 1.5 ± 0.3 1.2 ± 0.1 1.0 ± 0.1 1.8 ± 0.4 1.0 ± 0.2 0.087
vitamin C Cr 45.0 ± 3.9 48.1 ± 4.5 42.7 ± 6.0 49.7 ± 4.9 44.5 ± 4.1 47.1 ± 5.6 0.631 
(μmol·L-1) P 48.1 ± 2.9 43.0 ± 4.3 47.4 ± 4.6 41.7 ± 3.5 42.3 ± 5.1 44.1 ± 5.6 0.230
Values are presented as mean ± SEM (N = 9). Definitions: Cr, Creatine group; P, Placebo group. Effects present p-values for supplementation group x trial x timing of sample interaction effect and timing 
effect.
Creatine supplementation and oxidative stress
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potential to reduce ROS production through better maintenance 
of cellular energetics as well as quench ROS and other radical 
species. Indeed, oral creatine supplementation has been demon-
strated to reduce oxidative stress and prevent paracrystalline 
inclusions in a patient with mitochondrial dysfunction.19 A small 
number of randomised clinical trials have evaluated the effects 
of short- to moderate-term creatine supplementation in patients 
with diseases that have been traditionally associated with oxida-
tive stress, such as Huntington’s disease,39 Parkinson’s disease,40-42 
amyotrophic lateral sclerosis,43-45 rheumatoid arthritis,46 chronic 
obstructive pulmonary disease47 and congestive heart failure.38 
Although equivocal, these studies have generally reported small 
positive effects in a range of outcome measures. Nevertheless, 
no data from randomised clinical trials are currently available to 
evaluate the influence of creatine supplementation on oxidative 
stress in patient populations.
In summary, this is the first study to evaluate the effects of 
creatine supplementation on acute exercise-derived oxidative stress 
in healthy young males. Short-term creatine supplementation was 
ineffective in attenuating oxidative stress (as measured by serum 
hydroperoxide concentrations) induced by exhaustive cycling; in 
addition, supplementation did not influence LDL susceptibility to 
oxidative stress exercise or change plasma concentrations of anti-
oxidant vitamins. Nevertheless, it remains possible that creatine 
supplementation could benefit patient populations that have 
increased susceptibility to oxidative stress due to impaired cellular 
energy metabolism and decreased antioxidant defences.
Methods
Subjects. Eighteen healthy male volunteers (age: 21.5 ± 0.4 
years; stature: 1.77 ± 0.01 m; body mass: 81.1 ± 2.0 kg; body 
composition: 16.8 ± 0.7%BF) were informed about the potential 
risks of the study and gave written informed consent for their 
participation in the study, which was approved by a local research 
ethics committee. No subject had prior history of cardiovascular 
or respiratory disease and all subjects were non-smokers. Potential 
subjects attended an interview prior to undertaking the study and 
were subsequently excluded if they engaged in a structured weight 
training programme, or had taken creatine or other nutritional 
supplements in the 8 weeks prior to the study.
Experimental design. Prior to the main exercise trials, all subjects 
completed three incremental exercise tests (separated by exactly 7 
d) in order to ensure that the subjects were fully familiarized 
and able to repeat the exhaustive exercise protocol. Subjects then 
performed two main exercise trials, which consisted of incremental 
cycling that was continued until the individualized predetermined 
point of exhaustion (determined during the preliminary trials), 
and separated by exactly 7 d. Two days after completing the first 
main exercise trial (T1) the subjects were assigned, in a randomised 
double-blind fashion, to either a creatine (Cr) group or a placebo (P) 
group and instructed to take supplements for 5 d, which included 4 
d prior to and the day of trial two (T2). The subject characteristics 
of each group are presented in Table 4. The Cr group ingested 22.8 
g·d-1 Cr·H2O (equivalent to 5 g Cr x 4 daily) for 5 d. Each supple-
ment dose consisted of 5.7 g Cr·H2O and 5 g of glucose polymer 
change in intracellular creatine concentrations from T1 to T2 in 
Cr was insufficient to cause significant differences in lipid 
peroxidation. This finding suggests that increasing intramuscular 
creatine in healthy young males does not afford additional protec-
tion against oxidative damage derived from strenuous concentric 
muscle activity.
Supplementation did not influence t1/2max LDL oxidation 
(Table 3). As t1/2max LDL oxidation measures the resistance of 
LDL particles to oxidation, these data suggest that creatine did not 
alter the antioxidant defences of LDL particles in healthy young 
males. Unlike the current data, some recent studies have previ-
ously demonstrated that prolonged exercise involving considerable 
eccentric muscular activity causes significant increases in LDL 
resistance to peroxidation in healthy males.23,37 These equivocal 
results probably reflect increased mobilisation of antioxidant 
defences following prolonged exercise that leads to muscle damage 
and acute inflammation.
Similar doses of creatine have been repeatedly demonstrated to 
enhance short-term exercise performance in healthy individuals, 
which has generally been ascribed to enhanced temporal energy 
buffering through increased intramuscular CrP.1 Supplementation 
did not influence peak values for heart rate, oxygen uptake, and 
blood glucose and lactate concentrations (Table 3); therefore 
the metabolic responses to matched exhaustive exercise were not 
changed by creatine supplementation. Nevertheless, Andrews 
et al.38 showed that creatine supplementation attenuated blood 
concentrations of lactate and ammonia responses to exhaustive 
handgrip dynamometry exercise in patients with chronic heart 
failure. Consequently, creatine supplementation might be more 
effective in maintaining cellular energy supply in patient popula-
tions; thereby, reducing the accumulation of intracellular Ca2+, 
limiting the formation of reactive oxygen species (ROS) and 
attenuate oxidative damage.5
Although the current data does not support in-vivo antioxidant 
benefits, mediated by direct or indirect mechanisms, from short-
term creatine supplementation in healthy young males, it remains 
possible that individuals with diseases that are associated with 
reduced antioxidant defences and elevated radical production, 
probably through an impairment in cellular energy metabolism, 
might benefit from creatine supplementation. Creatine is unique, 
within the currently available antioxidants, in that it has the 
Table 4  Subject characteristics for creatine  
supplementation group (Cr) and placebo group 
(P)
Characteristic Cr (N = 9) P (N = 9) p-value
Age (dec. years) 21.7 ± 0.8 21.2 ± 0.2 0.638
Mass (kg) 77.9 ± 2.8 84.3 ± 2.5 0.103
Height (m) 1.77 ± 0.02 1.77 ± 0.01 0.956
Body composition (%BF) 18.2 ± 0.8 15.4 ± 1.0 0.061
Maximal oxygen uptake 50.8 ± 1.9 48.0 ± 1.7 0.290 
(ml·kg-1·min-1)
Values are mean ± SEM. p-value calculated using independent sample t-test.
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exhaustion (postexhaustion) for the analysis of blood lactate 
and glucose concentrations. Ambient temperature and humidity 
were recorded at the beginning and end of exercise (ETHG-912; 
Oregan Scientific, USA).
Blood sampling and analysis. Venous blood was collected in a 
5 mL container (Becton-Dickinson Ltd., UK) containing the anti-
coagulant ethylenediamine tetraacetic acid (EDTA). Several small 
aliquots were removed for the triplicate determination of blood 
lactate concentration, glucose concentration (YSI 2300, Yellow 
Springs Instruments, US), hemoglobin concentration (Hemocue 
Ltd., UK), hematocrit (Micro hematocrit MK IV, Hawksley, 
UK) and changes in plasma volume were estimated as previously 
described.49 The remaining blood was centrifuged at 3,000 g for 
15 min to obtain plasma. An aliquot of plasma (100 μL) was 
added to 900 μL of freshly prepared 10% metaphosphoric acid, 
mixed and frozen at -70°C for subsequent vitamin C analysis. The 
remaining plasma was frozen in aliquots and stored at -70°C prior 
to subsequent analysis. Two additional 7 mL blood samples were 
collected in serum separation tubes (Becton-Dickinson Ltd., UK), 
left to stand for 15 min then centrifuged at 3,000 g for 15 min to 
obtain serum. The serum was transferred to appropriate containers 
and subsequently stored at -70°C prior to analysis.
Serum hydroperoxide concentrations were measured as described 
in McEneny et al.50 Low density lipoprotein was isolated from 
plasma and oxidised according to the method of McDowell et al.51 
Subsequently, the production of conjugated dienes was followed 
in triplicate at 234 nm (SpectraMax 190; Molecular Devices 
Corp., US) using the computer software SoftMax Pro Version 3.0 
(Molecular Devices Corp., US); the change in absorbance (from 
baseline to the maximum absorbance following the propagation 
dissolved in 500 ml of warm water. This regimen was adopted in 
light of the work by Harris et al.2 who found that this protocol 
resulted in significant increases in total creatine content of resting 
quadriceps femoris muscle; in addition, the majority of studies that 
have shown a direct or indirect increase in total creatine concen-
tration have used similar supplementation regimes. Dissolving 
creatine in warm water prevented any detectable formation of 
creatinine, with no parts of the supplement remaining undissolved. 
The placebo group consumed 40 g·d-1 of glucose polymer. Both 
supplements had similar taste, texture and appearance, and were 
administered in generic packaging. Subjects were instructed to 
maintain their normal diet and activity patterns throughout the 
study. Food was weighed and recorded by the subjects for 2 d prior 
to each exercise trial and for 1 d afterwards. These food records 
were subsequently analyzed using commercial software (CompEat 
version v5.8.0; Nutrition Systems, UK). In addition, the subjects 
were instructed to abstain from strenuous exercise for 3 d before 
and 1 d following each trial. At the completion of the study all 
subjects gave their verbal assurance that they had complied with all 
instructions. The experimental design is illustrated in Figure 2.
Preliminary procedures. Subjects were habituated with the 
exercise protocol on three separate occasions prior to the main 
exercise trials. After a 5-min warm-up at 60 W and a 3-min rest 
period the subjects completed an incremental exercise test on an 
electromagnetically braked cycle ergometer (Lode Excalibur Sport; 
Lode, Holland). The work rate began at 60 W and thereafter 
increased in 10-W increments every 1 min until volitional exhaus-
tion, which was defined as an inability to maintain a cadence of 60 
rev min-1 despite verbal encouragement. The time to exhaustion 
during the preliminary tests were used to determine the exercise 
time for the main exercise trials; therefore, the individualised exer-
cise protocol was recorded and repeated during both main exercise 
trials. Heart rate (S810; Polar Electro Oy, Finland) and breath-by-
breath respiratory parameters (Oxycon Pro; Jaeger, Germany) were 
simultaneously recorded throughout exercise. Breath-by-breath 
oxygen uptake during exercise was used to calculate net oxygen 
uptake.
During the initial preliminary session, mass (model 712; Seca, 
Germany) and stature (Portable Stadiometer; Holtain, UK) were 
measured; additionally, percentage body fat (BF) was determined 
using bioelectrical impedance analyses (Quadscan; Bodystat, Isle of 
Man), as previously described.48
Main trial procedures. On the day of each main exercise trial 
the subjects reported to the laboratory at approximately the same 
time of day (±1 h) and following an overnight fast. After 5-min of 
cycling at 60 W and a 3-min rest period the subjects completed 
the individualized incremental cycling protocol. Subjects were 
instructed to pedal at a constant cadence between 65 and 75 
rev min-1. Heart rate (S810; Polar Electro Oy, Finland), and 
breath-by-breath respiratory parameters (Oxycon Pro; Jaeger, 
Germany) were simultaneously recorded throughout exercise. 
Blood samples were taken by venepuncture (Vacutainer system; 
Becton-Dickinson Ltd., UK) in a seated position from an antecu-
bital vein before exercise (preexercise), 20 min after the completion 
of exercise (postexercise), and 24 h after the trial (Post24 h). 
Additional capillary blood samples were taken immediately after 
Figure 2. Schematic diagram representing the experimental design that 
was used to evaluate the role of creatine supplementation on exercise-
induced cardiovascular function and oxidative stress. After repeated 
familiarization, the subjects performed two main exercise trials that con-
sisted of exhaustive incremental cycling. Two days after completing the 
first main exercise trial (T1) the subjects were assigned, in a randomised 
double-blind fashion, to either a creatine (Cr) group or a placebo (P) 
group and instructed to take supplements for 5 d, which included 4 d 
prior to and the day of trial two (T2).
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phase) was used to quantify conjugated diene concentration, 
and the time taken to reach half of the maximum oxidation 
(t1/2max LDL oxidation), which directly correlates with conjugated 
diene lag time, was taken as a measure of the resistance of the 
particle to oxidation. The duration of the conjugated diene lag 
time has been shown to correlate with endogenous antioxidants 
in LDL.52 Vitamin C concentrations were determined using 
a fluorimetric assay using a centrifugal analyser with fluores-
cence attachment according to the method of Vuilleumier and 
Keck.53 Plasma concentrations of retinol, α-carotene, β-carotene, 
α-tocopherol, γ-tocopherol and lycopene were measured by 
high-performance lipid chromatography with electrochemical 
detection according to the methods of Craft.54 The intra-assay 
coefficient of variance (%CV) for these assays ranged from 1.4 for 
α-tocopherol to 12.0 for lycopene.
Statistical analysis. Statistical analysis was carried out using 
SPSS software (version 13.0; SPSS Inc., IL, US). Group data were 
expressed as mean ± SEM and statistical significance was set at 
the p < 0.05 level. All data were assessed for normality (Shapiro-
Wilk’s test) and data that were not normally distributed (plasma 
retinol, α-tocopherol and lycopene concentrations) were log trans-
formed prior to analyses. Subject characteristics were compared 
under supplementation groups using independent samples t-tests 
(Table 1). Environmental conditions were compared using paired 
samples t-tests. Body composition, heart rate and whole-body 
oxygen uptake measurements were assessed using mixed-model 
repeated measures ANOVA (within-subject factors: trials; between-
subject factor: supplementation groups). The remaining data, 
which contained multiple time points during each trial, were 
analysed using mixed-model repeated measures ANOVA (within 
subject factors: trial x time of sample; between subject factor: 
group). Mauchly’s test was consulted and Greenhouse-Geisser 
correction was applied if the assumption of sphericity was violated. 
If a significant p value was identified for the three-way interac-
tion (group x trial x time of sample), the subject groups reacted 
differently and supplementation was deemed to have had a 
significant effect. Where a significant p value was identified for the 
main effect of time (time of sample), multiple pairwise compari-
sons were made using Bonferonni confidence interval adjustment.
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